Monday, February 26, 2024 9:22:23 PM
The Board unanimously approved and recommended seeking shareholder approval of this Reverse Split Proposal, on February 21, 2024.
Even if the shareholders approve the Reverse Split Proposal, we reserve the right not to affect any reverse stock split if the Board does not deem it to be in the best interests of our shareholders. The Board believes that granting this discretion provides the Board with maximum flexibility to act in the best interests of our shareholders. If this Reverse Split Proposal is approved by the shareholders, the Board will have the authority, in its sole discretion, without further action by the shareholders, to affect a reverse stock split.
The Board’s decision as to whether and when to effect the reverse stock split will be based on a number of factors, including prevailing market conditions, existing and expected trading prices for our Common Stock, actual or forecasted results of operations, and the likely effect of such results on the market price of our Common Stock.
https://www.otcmarkets.com/filing/html?id=17307889&guid=Bcd-kq5omGj4B3h
Recent FDCT News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 04:31:32 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 02/26/2024 10:12:50 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/03/2024 10:17:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/14/2023 05:27:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:35:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 02:30:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:58:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2023 08:10:11 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/28/2023 05:32:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 07:00:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:45:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:30:38 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 07:00:46 PM
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM